TP53 and cancer: Treatment of MDA-MB-231 with RSF EtOAc resulted in a significant increase in levels of p53 (Figure 3), a key tumor suppressor/regulatory gene in apoptosis induction following DNA damage caused by anti-cancer agents [16,17], resulting in growth arrest of cells in G1 phase or apoptosis [18,19].